LEO Pharma

At LEO Pharma, quality and patient safety are our top priorities! 🦁   We are proud to share that our production facilities have undergone 19 successful inspections by local and international authorities in the past year 🎯   🔎 From the production of the active ingredient (API) to the manufacture of finished dermatology products, our entire manufacturing process is subject to meticulous quality assurance and control, adhering strictly to Good Manufacturing Practice standards.   We continuously refine our quality processes, embrace digitalization and harness the power of AI to analyze data, uncover trends, and anticipate challenges—streamlining lead times to deliver excellence in quality. Regular reviews, comprehensive analyses, and ongoing improvements ensure that our production processes consistently uphold the highest standards of quality. By integrating regulatory intelligence, we work hard to ensure that our products always meet the highest manufacturing criteria 🤝   #LEOPharma #Quality #Safety #Digitization #Dermatology #Technology Pierre ANDRE

📣 NEWS: Skin diseases have been recognized as a global public health priority at the 78th World Health Assembly (WHA78).   🙌In a historic move to elevate skin health on the global public health agenda, the World Health Organization has passed a resolution that represents a transformative step toward addressing the needs of up to 2 billion people affected by skin conditions worldwide. With every individual, there can be a strain on families and communities. And the societal and economic consequences expand. Skin conditions can affect performance and mean lost days in school and at work. They can force people to change their life plans and jobs. They are giving rise to isolation, depression and anxiety.   Our CEO, Christophe Bourdon said “At LEO Pharma, we are deeply committed to transforming the standard of care in medical dermatology, and we see this resolution as a powerful reinforcement of the importance of our continued innovation to create lasting and meaningful impact for those living with skin conditions.”   The resolution mandates the development of a Global Action Plan, focusing on prevention, early detection, effective treatment, and long-term care. It also emphasizes promoting equitable access to affordable, high-quality services and integrating skin health into broader health systems🤝   #LEOPharma #WHA78 #GlobalPublichHealth #GlobalSkin #SkinDiseasesResolution

Last month, the esteemed newspaper Berlingske recognized Anne Jensen, our Vice President of Strategy, as one of the 100 most promising young talents in Denmark💡 Today, she is highlighted with a full portrait showcasing her impressive journey and accomplishments. At 32, Anne is shaping the future of LEO Pharma with her exceptional leadership. She brings presence and nerve to her role, helping to define complex strategies and then making them relatable across our global organization🌍 Her vision and dedication are instrumental in building on our 116-year legacy and driving LEO Pharma toward a successful future🦁 #Talent100 #Leadership #Strategy #Innovation #LEOPharma

How do we meet the unmet needs of 100 million people every year? 🌍   💡 Serving patients across the globe with unique health challenges requires constant innovation. It’s about thinking outside the box, uncovering what’s been overlooked, and challenging the status quo🔎   Our people are the key to our success. By attracting a broad talent pool of bright minds from various cultures and backgrounds, and fostering an inclusive culture of respect, we unlock fresh perspectives that drive the development of new treatments for patients worldwide💚 🎬 Hit play to discover more about who we are—all 4,000 of us who make up LEO Pharma 👇 #LEOPharma #WorldDayForCulturalDiversity #Diversity #Inclusion #People

🌍 At LEO Pharma, we are proud to have a presence in over 70 markets, reaching nearly 100 million people every year. This is quite a reach - So how is this possible? 🔎 🤝 More than half of our markets are Alliance Markets, where we partner with trusted local organizations to distribute our products. These partnerships allow us to extend our reach and ensure we can make a meaningful difference in the lives of patients worldwide. Recently, we were thrilled to welcome partners from more than 40 of our Alliance Markets to our Alliance Days in Milan. For 3 engaging days, we aligned on strategy, shared best practices, and strengthened the spirit of collaboration that drives our shared success 💡 Our CEO, Christophe Bourdon, said: "Our Alliance Markets are a vital part of our global strategy. With approximately 1 in 3 people worldwide affected by skin diseases, these partnerships are essential in helping us extend our reach, serve more patients, and advance care for those who need it most." 🎬 Hit play to hear from Khalid AOUIDAT, Vice President of Rest of World, Sebastian Spyropoulos, Alliance Lead, EU/SEA and Mohamed Helmi, Alliance Lead, MENA/LATAM as they share more about what the Alliance Markets are and why Alliance Days is such an important event👇 #LEOPharma #AllianceDays #AllianceMarkets #Partnership

Last week, nearly 130 talented colleagues from our incredible team in France—including sales reps, medical science liaisons, and the dedicated people supporting them—came together to celebrate successes, share ideas, and prepare for an exciting quarter ahead🙌   Karine Duquesne, General Manager of LEO Pharma in France, shared: "You can’t sell a brand or product, without truly believing it’s the best out there—a real game-changer for the people who need it. And this team? They don’t just believe it—they live it every day.."   💚A heartfelt THANK YOU to everyone who participated! Your dedication and passion are the driving force behind our mission to bring treatments to 100 million people worldwide each year🌟 #LEOPharma #Dermatology #BeyondTheSkin LEO Pharma France

A solid start to 2025! In the first quarter of the year, we have significantly increased profitability, driven by double digit growth in our dermatology portfolio. Our CEO Christophe Bourdon said “We have seen a good start to 2025, with key milestones achieved for our innovation pipeline. A significant highlight is the acceleration of the STAT6 program through our new partnership with Gilead. Additionally, the return to a positive net result marks another key milestone for the quarter, as we continue to develop the foundations for LEO Pharma’s long-term financial strength,” 👉 Swipe through the financial highlights below or read the full three-month interim report (Q1) 2025 to learn more: https://lnkd.in/etbTq-Y #LEOPharma #Q1 #FinancialResults #Results #Dermatology

📣NEWS: Our 2025 Q1 results are out! Let’s take you through the highlights👇   📈Revenue grew 9% (CER) year-on-year to DKK 3,373 million. 💡 Dermatology revenue grew 10% (CER) year-on-year to DKK 2,727 million. 🌎North America revenue grew 45% (CER) year-on-year. ✅We doubled our adjusted EBITDA margin from 8% to 16%. 🎯The 2025 financial outlook for revenue growth of 6-9% (CER) and an adjusted EBITDA margin of 15-18% is unchanged and confirmed. 🎬Hit play to hear from our CEO Christophe Bourdon as he elaborates on this quarter’s performance or visit https://lnkd.in/etbTq-Y to read the full three-month interim report (Q1) 2025. #LEOPharma #FinancialResults #Results

How do we create value for society?💚 Hit play to find out! At LEO Pharma we are committed to developing treatments that go beyond the skin. We want to help people lead better lives, free from the itch and pain that so many people living with skin diseases suffer from. How? By hiring top talent, supporting high-quality research, entering strategic partnerships and giving back through donations. Learn more in the video below👇 #LEOPharma #Dermatology #GivingBack

Congratulations, Pope Leo!   A name we know well, one that has stood for innovation, care, and dedication to patients for over a century. At LEO Pharma, it represents a proud legacy of making a meaningful difference in people's lives and serves as a powerful reminder of the lion-hearted courage we all need to create a lasting global impact.